Vilket är priset för Hancock Jaffe Laboratories (HJLI)

Priset för Hancock Jaffe Laboratories (HJLI) är $10.38

Vilket är marknadsvärdet för Hancock Jaffe Laboratories (HJLI)

Marknadsvärdet för Hancock Jaffe Laboratories (HJLI) är $4.55M

Hancock Jaffe Laboratories (HJLI) Utestående Aktier

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

År	Utestående aktier	Ändra
Inte tillräckligt med data för de angivna datumen.

År

Utestående aktier

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	Utestående aktier	Skillnad	Land
Abbott Laboratories ABT.US	1.74B	-	US
Stryker Corporation SYK.US	383.50M	-	US
Medtronic plc MDT.US	1.28B	-	IE
Boston Scientific Corporation BSX.US	1.48B	-	US
Edwards Lifesciences Corporation EW.US	576.40M	-	US

Företag

Utestående aktier

Skillnad

Land